SCHEMBL14907744

SCHEMBL14907744

CCCCCn1c(N)c(C(=O)OC)c2nc3ccccc3nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 3/20 1.00
KDM4E B2RXH2 14/20 0.77
GLA P06280 9/20 0.77
SAE1 Q9UBE0 2/20 0.77
UBA2 Q9UBT2 2/20 0.77
ALDH1A1 P00352 14/20 0.72
HPGD P15428 14/20 0.72
GAA P10253 12/20 0.72
MAPT P10636 9/20 0.72
NSD2 O96028 3/20 0.72
CYP1A2 P05177 2/20 0.72
CYP3A4 P08684 2/20 0.72
CYP2C9 P11712 2/20 0.72
CYP2C19 P33261 2/20 0.72
CYP2D6 P10635 1/20 0.72
KMT2A Q03164 6/20 0.71
MEN1 O00255 5/20 0.71
HTT P42858 3/20 0.71
ALOX12 P18054 1/20 0.71
CASP1 P29466 9/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907745 0.99 GRK6 (1.00) GRK6KDM4EGLASAE1UBA2
SCHEMBL16171058 0.87 GRK6 (0.77) GRK6KDM4EGLASAE1UBA2
SCHEMBL16171183 0.86 GRK6 (0.78) GRK6KDM4EGLASAE1UBA2
SCHEMBL14907727 0.80 GRK6 (1.00) GRK6KDM4EGLASAE1UBA2
SCHEMBL6980640 0.79 GRK6 (0.70) GRK6KDM4EGLASAE1UBA2
SCHEMBL18153563 0.78 KDM4E (0.74) GRK6KDM4EGLASAE1UBA2
SCHEMBL15032613 0.73 KDM4E (1.00) KDM4EGLASAE1UBA2ALDH1A1
SCHEMBL29365795 0.73 KDM4E (0.69) GRK6KDM4EGLASAE1UBA2
SCHEMBL1813777 0.73 KDM4E (0.69) GRK6KDM4EGLASAE1UBA2
SCHEMBL9162749 0.72 ALDH1A1 (0.57) GRK6KDM4EGLASAE1UBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885KDM4E 4504/4885GLA 2667/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885KDM4E 4504/4885GLA 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.